Stay updated on PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Sign up to get notified when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.

Latest updates to the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for the 89Zr-trastuzumab PET/CT study is displayed, with details on its eligibility criteria, study procedures, outcome measures, and record history. The record indicates the study was withdrawn for insufficient staff, with zero actual enrollment and no location data.SummaryDifference34%

- Check13 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the agency’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, replacing the previously visible study details with an error view. The removals indicate core study data such as sponsor, investigators, and outcomes are no longer visible on the page.SummaryDifference15%

Stay in the know with updates to PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.